Hollo is a health-tech social enterprise with a platform of research-backed Digital Therapeutics, that uses proprietary Behavioral Health AI to create sustainable health plans for chronically ill patients. The company, founded in 2020 and headquartered in Hong Kong S.a.r., has gained recognition for its innovative approach, winning awards for its focus on developing digital therapeutics to be accessible by all. Through extensive research and clinical studies with research partners, Hollo is closely generating software and AI models to ensure the effectiveness and accessibility of their digital therapeutics. Most recently, the company secured an impressive HKD900.00K grant investment on 01 February 2024. With its commitment to improving mental health and leveraging technology, Hollo presents itself as an intriguing opportunity for potential investors in the health care and information technology industries.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | HKD900.00K | - | 01 Feb 2024 | |
Angel Round | HKD400.00K | - | 01 Sep 2023 | |
Angel Round | HKD100.00K | - | 01 Jul 2022 | |
Angel Round | HKD880.00K | - | 01 Jun 2022 | |
Grant | HKD800.00K | - | 01 Jan 2022 |
No recent news or press coverage available for Hollo .